Clinuvel Pharmaceuticals Limited operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Clinuvel Pharmaceuticals Limited with three other
companies in this sector in AUSTRALIA :
sales of 47.97 million Australian Dollars [US$34.42 million]
of which 100%
was Adult Stem Cell Development),
(35.36 million Australian Dollars [US$25.36 million]
of which 89%
was Clinical Trials), and
Idt Australia Limited.
(14.17 million Australian Dollars [US$10.16 million]
During the year ended June of 2020, sales at
Clinuvel Pharmaceuticals Limited were A$33.13 million (US$23.76 million).
increase of 4.8%
versus 2019, when the company's sales were A$31.61 million.
This was the fifth consecutive year of sales increases at Clinuvel Pharmaceuticals Limited
(and since 2015, sales have increased a total of 804%).